Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for RIZATRIPTAN

Ingredient

RIZATRIPTAN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
SANDOZ RIZATRIPTAN ODT	10MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2021-07-12	2021-07-19	142315
SANDOZ RIZATRIPTAN ODT	5MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2020-05-04	2020-06-22	113906
SANDOZ RIZATRIPTAN ODT	5MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2025-01-13	2025-04-01	247620
SANDOZ RIZATRIPTAN ODT	5MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2022-10-04	2022-10-20	171083
TEVA-RIZATRIPTAN ODT	10MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2023-10-05	2023-11-09	206428
TEVA-RIZATRIPTAN ODT	10MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2023-02-09	2023-04-28	184213
TEVA-RIZATRIPTAN ODT	10MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2020-09-24	2020-10-30	124992
TEVA-RIZATRIPTAN ODT	10MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2019-08-22	2019-11-21	92154
TEVA-RIZATRIPTAN ODT	10MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2017-05-10	2017-09-19	9805
TEVA-RIZATRIPTAN ODT	5MG	TABLET (ORALLY DISINTEGRATING)	Resolved	2022-09-22	2023-04-28	169983

Previous
1
…
6
7
8
9
Next

Showing 71 to 80 of 83

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
MINT-RIZATRIPTAN ODT	10MG	TABLET (ORALLY DISINTEGRATING)	Discontinued	2017-06-21	2017-07-01	13553

Showing 11 to 11 of 11